Search

When interacting with absorption materials, beta rays, which are emitted by isotopes, are harmful because bremsstrahlung (braking) radiation is produced. Therefore, the efficiency of a shielding material can be improved by considering the bremsstrahlung radiation generated by the material's beta ray absorption. In this study, to determine the risk of bremsstrahlung radiation produced by beta rays, the fractions of beta energy transformed into bremsstrahlung radiation were calculated for beta emitters in the energy ranges of 0.0026-0.1734, 0.205-0.694, and 0.9345-2.640 MeV, using five different absorption materials (13Al, 26Fe, 48Cd, 74W, and 82Pb). The relationship between the fractions of beta energy transformed into bremsstrahlung radiation by the five shielding materials and the maximum energies of some beta emitters was studied to determine the most suitable beta-ray shielding materials to effectively minimize bremsstrahlung radiation. The results showed that the fractions of beta energy transformed into bremsstrahlung radiation increased as the beta energy and the atomic number of the shielding material increased. The fraction of beta energy transformed into bremsstrahlung radiation in 13Al < 26Fe < 48Cd < 74W < 82Pb. Therefore, beta ray shields should be made with low atomic number materials to reduce the generation of bremsstrahlung radiation. Practically, beta shields made from materials with atomic numbers greater than 13 are rarely employed; notably, aluminum successfully decreased the production of bremsstrahlung radiation. However, it is also necessary to use materials with medium and high atomic numbers as secondary beta shields to reduce the effect of the bremsstrahlung radiation photons formed by the interaction between beta rays and shielding materials. [ABSTRACT FROM AUTHOR]

The development of high-Z (high atomic number) radiation shielding materials is vital in order to protect personnel who work with harmful gamma radiation sources. At the same time, the emission of external bremsstrahlung (EB) radiation in those shielding materials when the radiation source emits beta particles as well as gamma radiation is also of prime concern.The production of EB in films of lead monoxide (PbO) loaded polycarbonate (PC) composite at eleven different filler levels (FLs) varying, in terms of weight fraction, from 0.0 % up to 10.0 % were investigated experimentally by using beta particles from strontium-90/yttrium-90 (90Sr/90Y) radioactive source. A nonlinear relation is observed between EB intensity and target thickness. The effective atomic numbers of the prepared PbO-filled PC composite films (at different FLs) were determined via EB measurements, followed by calculations, and the values obtained were compared with the modified atomic numbers which were determined for the same composite films (at different FLs) using the Markowicz and Van Grieken equation, and it was found that they are in good agreement. Finally, the atomic number dependence of EB in these composite films (PbO-filled PC composites) has been studied. It is obtained that the intensity of EB spectra depends on the square of the atomic number of the target material.

Targeted therapies for multiple myeloma (MM) include the anti-CD38 antibody daratumumab, which, in addition to its inherent cytotoxicity, can be radiolabeled with tracers for imaging and with β- and α-emitter radionuclides for radioimmunotherapy. Methods: We have compared the potential therapeutic efficacy of β- versus α-emitter radioimmunotherapy using radiolabeled DOTA-daratumumab in a preclinical model of disseminated multiple myeloma. Multiple dose levels were investigated to find the dose with the highest efficacy and lowest toxicity. Results: In a dose–response study with the β-emitter 177Lu-DOTA-daratumumab, the lowest tested dose, 1.85 MBq, extended survival from 37 to 47 d but did not delay tumor growth. Doses of 3.7 and 7.4 MBq extended survival to 55 and 58 d, respectively, causing a small equivalent delay in tumor growth, followed by regrowth. The higher dose, 11.1 MBq, eradicated the tumor but had no effect on survival compared with untreated controls, because of whole-body toxicity. In contrast, the α-emitter 225Ac-DOTA-daratumumab had a dose-dependent effect, in which 0.925, 1.85, and 3.7 kBq increased survival, compared with untreated controls (35 d), to 47, 52, and 73 d, respectively, with a significant delay in tumor growth for all 3 doses. Higher doses of 11.1 and 22.2 kBq resulted in equivalent survival to 82 d but with significant whole-body toxicity. Parallel studies with untargeted 225Ac-DOTA-trastuzumab conferred no improvement over untreated controls and resulted in whole-body toxicity. Conclusion: We conclude, and mathematic modeling confirms, that maximal biologic doses were achieved by targeted α-therapy and demonstrated 225Ac to be superior to 177Lu in delaying tumor growth and decreasing whole-body toxicity.

Acute hematologic toxicity is a frequent adverse effect of beta-emitter targeted radionuclide therapies (TRTs). Alpha emitters have the potential of delivering high linear energy transfer (LET) radiation to the tumor attributed to its shorter range. Antibody-based TRTs have increased blood-pool half-lives, and therefore increased marrow toxicity, which is a particular concern with alpha emitters. Accurate 3D absorbed dose calculations focusing on the interface region of blood vessels and bone can elucidate energy deposition patterns. Firstly, a cylindrical geometry model with a central blood vessel embedded in the trabecular tissue was modeled. Monte Carlo simulations in GATE were performed considering beta (177Lu, 90Y) and alpha emitters (211At, 225Ac) as sources restricted to the blood pool. Subsequently, the radioactive sources were added in the trabecular bone compartment in order to model bone marrow metastases infiltration (BMMI). Radial profiles, dose-volume histograms and voxel relative differences were used to evaluate the absorbed dose results. We demonstrated that alpha emitters have a higher localized energy deposition compared to beta emitters. In the cylindrical geometry model, when the sources are confined to the blood pool, the dose to the trabecular bone is greater for beta emitting radionuclides, as alpha emitters deposit the majority of their energy within 70 μm of the vessel wall. In the BMMI model, alpha emitters have a lower dose to untargeted trabecular bone. Our results suggest that when alpha emitters are restricted to the blood pool, as when labeled to antibodies, hematologic toxicities may be lower than expected due to differences in the microdistribution of delivered absorbed dose.

Interest in the use of 225Ac for targeted alpha therapies has increased dramatically over the past few years, resulting in a multitude of new isotope production and translational research efforts. However, 225Ac radioimmunoconjugate (RIC) research is still in its infancy, with most prior experience in hematologic malignancies and only one reported preclinical solid tumor study using 225Ac RICs. In an effort to compare 225Ac RICs to other current antibody conjugates, a variety of RICs are tested against intractable small-cell lung cancer (SCLC). We directly compare, in vitro and in vivo, two promising candidates of each α or β- category, 225Ac and 177Lu, versus pyrrolobenzodiazepine (PBD) nonradioactive benchmarks. The monoclonal antibody constructs are targeted to either delta like 3 protein (DLL3), a recently discovered SCLC target, or CD46 as a positive control. An immunocompromised maximum tolerated dose assay is performed on NOD SCID mice, along with tumor efficacy proof-of-concept studies in vivo. We overview the conjugation techniques required to create serum-stable RICs and characterize and compare in vitro cell killing with RICs conjugated to nonspecific antibodies (huIgG1) with either native or site-specific thiol loci against tumor antigen DLL3-expressing and nonexpressing cell lines. Using patient-derived xenografts of SCLC onto NOD SCID mice, solid tumor growth was controlled throughout 3 weeks before growth appeared, in comparison to PBD conjugate controls. NOD SCID mice showed lengthened survival using 225Ac compared to 177Lu RICs, and PBD dimers showed full tumor suppression with nine out of ten mice. The exploration of RICs on a variety of antibody-antigen systems is necessary to direct efforts in cancer research toward promising candidates. However, the anti-DLL3-RIC system with 225Ac and 177Lu appears to be not as effective as the anti-DLL3-PBD counterpart in SCLC therapy with matched antibodies and portrays the challenges in both SCLC therapy as well as the specialized utility of RICs in cancer treatment.

In the present study, liquid scintillation counting triple to double coincidence ratio technique is used to ascertain the gross α and β activity in groundwater samples collected from the Beldih mine region in the vicinity of the South Purulia Shear Zone (SPSZ) of Chota Nagpur Plateau in eastern India. A total of sixty samples were collected from deep tube wells located in the study area to assess the potential health threats caused by α and β emitting radionuclides present in these water samples. Average gross α activity in the region of study is 0.09 ± 0.05 Bq/L, with a maximum of 3.22 ± 0.07 Bq/L. On the other hand, the average gross β activity is found to be 0.13 ± 0.02 Bq/L, with a maximum of 0.29 ± 0.02 Bq/L. It was observed that gross α activity level in three samples exceeds the safety limit of 0.5 Bq/L recommended by the World Health Organization. No significant gross β activity was observed. However, the radiological parameters for assessment of potential health threats due to ionizing radiation have been observed to be significantly high for adults. The results of this study indicate that the radiological assessment of groundwater in the Beldih mine region may be extended in future., Competing Interests: Declarations Conflict of interest The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)

The method combining Monte Carlo (MC) simulation and mesh-type cell models provides a way to accurately assess the cellular dose induced by β -emitters. Although this approach allows for a specific evaluation of various nuclides and cell type combinations, the associated time cost for obtaining results is relatively high. In this work, we propose a Microdosimetric assessment method for Internal exposure of β -emitters based on Mesh-type Cell cluster models (abbreviated as MIMC- β ). This approach is applied to evaluate the dose in various types of cells (human bronchial epithelial cells, BEAS-2B; normal human liver cells, L-O2; and normal human small intestine epithelial cells, FHs74Int) exposed to β -emitters. Furthermore, microdosimetric quantity based on the cell cluster model are employed to estimate the relative biological effectiveness (RBE) of β -emitters. The results indicate that this method can accurately and rapidly predict cellular doses caused by different types of β -emitters, significantly mitigating the efficiency challenges associated with directly employing MC to estimate the overall dose of the mesh-type cell cluster model. In comparison with results obtained from direct simulations of uniform administration of β - sources using PHITS for validation, the cellular cluster overall S -values obtained through MIMC- β show discrepancies mostly below 5%, with the minimum deviation reaching 1.35%. Small sampling sizes within the cell nucleus led to larger average lineal energies. In comparison to C-14, the differences in cellular cluster average lineal energy for Cs-134, Cs-137, and I-131 are negligible, resulting in close numerical estimations of RBE based on lineal energy. The MIMC- β can be extended to diverse cell types and β -emitters. Additionally, the RBE assessment based on the cell cluster model offers valuable insights for predicting radiobiological damage resulting from internal exposure by β -emitters. This method is expected to find applicability in various realistic scenarios, including radiation protection and radioligand therapy., (© 2024 Institute of Physics and Engineering in Medicine. All rights, including for text and data mining, AI training, and similar technologies, are reserved.)

The current work was going to study the dosimetric properties of Egyptian muscovite minerals irradiated with β-rays using the thermoluminescence technique (TL). The analysis of the TL glow curves was done using the (T m  - T stop ) and the initial rise methods. The deconvolution of the muscovite glow curves was analyzed to have eight superimposed trapping peaks. These trapes were located at 0.72, 0.80, 0.98, 1.09, 1.19, 1.30, 1.50, and 1.59 eV. Muscovite samples were studied at doses up to 330 Gy and exhibited good linearity in relation to beta radiation. The kinetic parameters, sensitivity, and dosimetric characteristics were evaluated. High accuracy was achieved through the repeatability of TL measurements., (© 2024 John Wiley & Sons Ltd.)

Advances in the field of molecular biology have had an impact on biomedical applications, which provide greater hope for both imaging and therapeutics. Work has been intensified on the development of radionuclides and their application in radiopharmaceuticals (RPS) which will certainly influence and expand therapeutic approaches in the future treatment of patients. Alpha or beta particles and Auger electrons are used for therapy purposes, and each has advantages and disadvantages. The radionuclides labeled drug delivery system will deliver the particles to the specific targeting cell. Different radioligands can be chosen to uniquely target molecular receptors or intracellular components, making them suitable for personal patient-tailored therapy in modern cancer therapy management. Advances in nanotechnology have enabled nanoparticle drug delivery systems that can allow for specific multivalent attachment of targeted molecules of antibodies, peptides, or ligands to the surface of nanoparticles for therapy and imaging purposes. This review presents fundamental radionuclide properties with particular reference to tumor biology and receptor characteristic of radiopharmaceutical targeted therapy development. [ABSTRACT FROM AUTHOR]

The effect of melts from various groups of chemical compounds (NaCl, KCl, CaCl2, Li2CO3, H3BO3), their quantity, and charge calcination temperature on the yield of the target component (Zn2SiO4) was studied. The charge was calcined in the temperature range of 600–1100°С (step 100°С) with sampling, the phase composition of which was determined by X-ray phase analysis. [ABSTRACT FROM AUTHOR]

A new type of nuclear battery, based on the sandwich structure of solar cells and tritium gas‐filled radioluminescent glass tubes (RLGTs), is developed and used successfully as a low‐power source. The radioluminescence (RL) is produced by bombarding beta particles, emitted by tritium gas, on ZnS: Cu is coated on the inner cylindrical surface of a glass tube. The response of solar cells to the optical spectrum of RL is studied and corelated with the current–voltage characteristics of the nuclear battery. The results show that the short‐circuit current, maximum output power, and energy conversion efficiency are enhanced but nonlinearly, with the increase in the number of RLGTs and by mounting the sandwich structure on an aluminum or plastic holder which acts as light reflector. Three such nuclear batteries are developed using different types of solar cells and their electrical performance is studied. Use of the developed nuclear battery as a low direct current power source is demonstrated by operating a digital watch and a light‐emitting diode for long periods. [ABSTRACT FROM AUTHOR]

GYGAG(Ce) transparent ceramic garnet scintillators were irradiated with electrons from 0.5 to 2 MeV with fluences from $10^{16}\,\,\text{e}^{-}$ /cm2 to $10^{19}\,\,\text{e}^{-}$ /cm2, corresponding to doses from 0.3 to 310 Gigarad. Absorption spectra were measured before and after irradiations. Light yields from alpha, beta, and gamma excitations were measured before and after irradiation and compared to preirradiation values to gain a deeper understanding of how electron irradiations can affect light yield, as well as defects generated in both the surface and bulk. Within experimental error, no degradation in light yield was observed for the electron-irradiated samples, as measured via beta or gamma excitation, with minimal degradation observed via alpha excitation. A small increase in optical absorption near the wavelength of emission was observed following the largest dose irradiation. These results suggest that GYGAG(Ce) is radiation hard to electron irradiation up to $10^{19}\,\,\text{e}^{-}$ /cm2 and doses up to 310 Gigarad. This robustness to irradiation indicates that transparent ceramic garnets may prove useful for applications such as scintillation-based nuclear batteries by allowing for higher energy beta emitters, increased power densities, and enabling long service lifetimes. [ABSTRACT FROM AUTHOR]

Interlaboratory comparison exercises for determining the gross alpha and beta activity concentrations in drinking water, organized by the National Institute for Radiological Protection (NIRP), China CDC, have been carried out since 2012. The purpose of this study is to assess the accuracy and precision of gross alpha and beta analyses of low-level radioactivity concentrations. Natural water samples were used for the comparison, and the performance of the participating laboratories was evaluated with respect to the reference values using the Z-score performance indicator. The comparison data from 2012 to 2022 were analyzed, where the percentage of laboratories with acceptable results was 80-92%, and the dispersion of the measurement results across laboratories became smaller over time. The results demonstrate that these exercises can help laboratories to resolve issues in gross α/β analysis and improve the consistency of the measurement results., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)

The integration of the ORION digital signal processing-based MCA system coupled with a 3″ × 3″ NaI(Tl) detector assembly with a GM detector for counting beta (β) has eliminated the need for a standalone β-γ method in which U3O8 is determined by gross β and gross γ counting. Uraniferous and mixed U-Th samples were taken up for study and compared with the results obtained from Canberra p-type coaxial high resolution gamma ray spectrometry detector. In uraniferous samples, U3O8 values obtained are within ±10%, whereas in the case of mixed U-Th samples, U3O8 values are within ±15%. Regression graphs drawn between the outcomes from the two analytical systems indicate R2 > 0.95 for Ra(eU3O8) and ThO2. In uraniferous samples, the R2 value for U3O8 was found to be > 0.99, but in mixed U-Th samples, it is 0.92. The closeness of agreement between the results obtained from two methods at various concentrations over the analytical range shows that the integrated system is suitable for the quantitative determination of eU3O8, U3O8, Ra(eU3O8), ThO2 and K in geological rock samples., (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)

Human activities usually have some contamination as effluents from chemical industries and radionuclides from nuclear reactors. For assessing the probable radioactive contamination in vicinity of Tehran Research Reactor, The gross alpha and beta radioactivity concentrations in soil, pine and cedar leaves and some selected fruits (fig, apple, berry and pomegranate) were investigated using an alpha/beta spectrometer during 2021-2022. Also, the concentrations of artificial and natural radionuclides in samples were investigated by the method of gamma spectroscopy. The gross alpha activity concentrations in soil, pine and cedar leaves and some selected fruits samples are from 0.05 to 0.35 Bq/gr and 0.07-0.31 Bq/gr and 0.04-0.18 Bq/gr, respectively. The gross beta activity concentrations in soil, pine and cedar leaves and some selected fruit samples are from 0.73 to 4.25 Bq/gr and 0.21-3.97 Bq/gr and 1.01-2.71 Bq/gr, respectively. Average activities concentration of natural radionuclide 232 Th, 238 U and 40 K in soil, pine and cedar leaves and some selected fruits are 31.89-16.23-582.73 Bq/kg and 1.84-0.99-84.60 Bq/kg and 1.98-1.09-72.08 Bq/kg respectively. From artificial radionuclides, just 137 Cs is recognized in soil sample and the range of 137 Cs concentration in surface soils was observed to vary in the range 0.85-2.21 (Bq/kg). The result showed that the Tehran Research Reactor activities not have increased the environmental radioactivity and radiation level in the area., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)

Purpose: In radioguided surgery (RGS), radiopharmaceuticals are used to generate preoperative roadmaps (e.g., PET/CT) and to facilitate intraoperative tracing of tracer avid lesions. Within RGS, there is a push toward the use of receptor-targeted radiopharmaceuticals, a trend that also has to align with the surgical move toward minimal invasive robotic surgery. Building on our initial ex vivo evaluation, this study investigates the clinical translation of a DROP-IN β probe in robotic PSMA-guided prostate cancer surgery., Methods: A clinical-grade DROP-IN β probe was developed to support the detection of PET radioisotopes (e.g., 68  Ga). The prototype was evaluated in 7 primary prostate cancer patients, having at least 1 lymph node metastases visible on PSMA-PET. Patients were scheduled for radical prostatectomy combined with extended pelvic lymph node dissection. At the beginning of surgery, patients were injected with 1.1 MBq/kg of [ 68 Ga]Ga-PSMA. The β probe was used to trace PSMA-expressing lymph nodes in vivo. To support intraoperative decision-making, a statistical software algorithm was defined and optimized on this dataset to help the surgeon discriminate between probe signals coming from tumors and healthy tissue., Results: The DROP-IN β probe helped provide the surgeon with autonomous and highly maneuverable tracer detection. A total of 66 samples (i.e., lymph node specimens) were analyzed in vivo, of which 31 (47%) were found to be malignant. After optimization of the signal cutoff algorithm, we found a probe detection rate of 78% of the PSMA-PET-positive samples, a sensitivity of 76%, and a specificity of 93%, as compared to pathologic evaluation., Conclusion: This study shows the first-in-human use of a DROP-IN β probe, supporting the integration of β radio guidance and robotic surgery. The achieved competitive sensitivity and specificity help open the world of robotic RGS to a whole new range of radiopharmaceuticals., (© 2024. The Author(s).)

Abstract: Radionuclides emitting high-energy beta rays are frequently employed for therapeutic purposes in the field of medicine. However, it is widely recognized that such radionuclides have the potential to generate in vivo bremsstrahlung radiation. This research study focused on investigating the dose rate of bremsstrahlung radiation emanating from a radioactive source embedded in a patient. To accomplish this, we estimate the spectral energy distribution of the generated bremsstrahlung. By employing this spectral distribution, we present a novel method for estimating the bremsstrahlung dose rate kernel applicable to a given combination of source and material. This method considers photon buildup and attenuation, as well as the encapsulation of the radiation source. Furthermore, we provide formulas for both monoenergetic electrons and beta-transition electrons that account for radioactive decay., Competing Interests: Conflict of Interest and Sources of Funding: This work was supported by the Nuclear Regulatory Commission [contract number 31310019C0036]., (Copyright © 2024 Health Physics Society.)

The dosimetry of different minerals is carried out to investigate the dose received by the population in case of a nuclear accident. Retrospective dosimetry is a field where there is a continuous search to find new materials. Beach sand minerals, namely quartz and zircon, were exposed to beta and gamma radiation and studied separately. A comparison of the thermoluminescence (TL) output of different peaks of quartz for beta and gamma was studied. Comparison of quartz peaks with the TL output of zircon peaks was carried out. TL output for a constant dose of gamma is always higher compared to the TL output received due to beta., (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)

Peptide receptor radionuclide therapy (PRRT) has become mainstream therapy of metastatic neuroendocrine tumors not controlled by somatostatin analog therapy. Currently, beta particle-emitting radiopharmaceuticals are the mainstay of PRRT. Alpha particle-emitting radiopharmaceuticals have a theoretic advantage over beta emitters in terms of improved therapeutic efficacy due to higher cancer cell death and lower nontarget tissue radiation-induced adverse events due to shorter path length of alpha particles. We discuss the available evidence for and the role of alpha particle PRRT., Competing Interests: Disclosure S. Bhimaniya and H. Shah have no disclosure. H.A. Jacene has research support: Blue Earth Diagnostics, Inc; Lantheus Consulting: Advanced Accelerator Applications, Spectrum Dynamics Royalties: Cambridge Publishing; Honoraria: Blue Earth Diagnostics, Inc., Munrol., (Copyright © 2024 Elsevier Inc. All rights reserved.)

Advances in the field of molecular biology have had an impact on biomedical applications, which provide greater hope for both imaging and therapeutics. Work has been intensified on the development of radionuclides and their application in radiopharmaceuticals (RPS) which will certainly influence and expand therapeutic approaches in the future treatment of patients. Alpha or beta particles and Auger electrons are used for therapy purposes, and each has advantages and disadvantages. The radionuclides labeled drug delivery system will deliver the particles to the specific targeting cell. Different radioligands can be chosen to uniquely target molecular receptors or intracellular components, making them suitable for personal patient-tailored therapy in modern cancer therapy management. Advances in nanotechnology have enabled nanoparticle drug delivery systems that can allow for specific multivalent attachment of targeted molecules of antibodies, peptides, or ligands to the surface of nanoparticles for therapy and imaging purposes. This review presents fundamental radionuclide properties with particular reference to tumor biology and receptor characteristic of radiopharmaceutical targeted therapy development.

Beta particles radiation doses have important applications in medicine. In particular, curved and symmetric as well as curved and asymmetric applicators containing the beta emitting 106Ru/106Rh isotopes are widely used in radiotherapy for the treatment of various ocular diseases. Nevertheless, a great problem in the use of these applicators is the inaccurate determination of the dose rates around them. Difficulties arise mainly because of the very short distances involved, and in this scenario theoretical calculation methods play an important role. In this work a simple approach based on the beta-point dose function integration over the total surface of each plaque was used to estimate the dose rates along their central axis. Results of relative dose rates for concave and symmetric (CCA, CCB, CXS, CCX/Y/Z, CCD, CGD and CCC) and concave and asymmetric (CIA, CIB/CIB-2, COB and COC) ruthenium/rhodium plaque types are shown.

High-LET-type cell survival curves have been observed in cells that were allowed to incorporate 125I-UdR into their DNA. Incorporation of tritiated thymidine into the DNA of cells has also been shown to result in an increase in relative biological effectiveness in cell survival experiments, but the increase is smaller than observed after incorporation of 125I-UdR. These findings are explained in the literature by the overall complexity of the induced DNA damage resulting from energies of the ejected electron(s) during the decay of 3H and 125I. Chromosomal aberrations (CA) are defined as morphological or structural changes of one or more chromosomes, and can be induced by ionizing radiation. Whether the number of CA is associated with the linear energy transfer (LET) of the radiation and/or the actual complexity of the induced DNA double-strand breaks (DSB) remains elusive. In this study, we investigated whether DNA lesions induced at different cell cycle stages and by different radiation types [Auger-electrons (125I), β- particles (3H), or γ radiation (137Cs)] have an impact on the number of CA induced after induction of the same number of DSB as determined by the γ-H2AX foci assay. Cells were synchronized and pulse-labeled in S phase with low activities of 125I-UdR or tritiated thymidine. For decay accumulation, cells were cryopreserved either after pulse-labeling in S phase or after progression to G2/M or G1 phase. Experiments with γ irradiation (137Cs) were performed with synchronized and cryopreserved cells in S, G2/M or G1 phase. After thawing, a CA assay was performed. All experiments were performed after a similar number of DSB were induced. CA induction after 125I-UdR was incorporated was 2.9-fold and 1.7-fold greater compared to exposure to γ radiation and radiation from incorporated tritiated thymidine, respectively, when measured in G2/M cells. In addition, measurement of CA in G2/M cells after incorporation of 125I-UdR was 2.5-fold greater when compared to cells in G1 phase. In contrast, no differences were observed between the three radiation qualities with respect to exposure after cryopreservation in S or G1 phase. The data indicate that the 3D organization of replicated DNA in G2/M cells seems to be more sensitive to induction of more complex DNA lesions compared to the DNA architecture in S or G1 cells. Whether this is due to the DNA organization itself or differences in DNA repair capability remains unclear., (©2024 by Radiation Research Society. All rights of reproduction in any form reserved.)

In the present work, glass samples in the (100 - x)B 2 O 3 -xLi 2 O binary system, with x varying from 30 to 50 mol%, were prepared using the conventional melting and moulding method, with the main objective of evaluating the thermoluminescence response when exposing these materials to ultraviolet (UV) radiation. Complementary analysis based on density, optical absorption on the UV-visible region (UV-vis absorbance), Fourier transform infrared spectroscopy on the medium region, X-ray diffraction, and differential thermal analysis measurements were performed. Thermoluminescence measurements of vitreous samples showed glow curves with at least one peak with a maximum temperature of ~170°C after exposure to UV radiation in the temperature range 50-250°C. Samples were also exposed to beta radiation in the temperature range 25-275°C, also showing single peaks with a maximum temperature of ~150°C., (© 2024 John Wiley & Sons Ltd.)

Plaques containing beta-emitting isotopes have several medical applications. In particular, due to the short range of beta particles and the rapid fall off of dose rates they are suitable to be used in small and superficial skin cancer therapy, killing the tumor cells and preserving the underlying healthy structures. The analytical/numerical beta-point dose function formalism is used to a simple estimate of the relative dose rates around square and rectangular beta applicator containing the Yttrium-90 isotope. Maximum differences in relative dose rates along central axis of 13% at 6.6 mm depth and 20% at 5 mm depth were found, respectively, for the square and rectangular plaques as compared with the literature measurements data. Results have also indicated that for both plaques dose rates fall off to 50% of the reference value at about 2 mm depth; drop to just 10% at 4.5 mm depth, and become zero from 8 mm on. This fact confirms that these sources are suitable to be used in superficial skin cancer therapy. The method presented here may be used to estimate the relative dose rates around square and rectangular Y-90 beta applicators in a simple and fast way.

In this work we present results of relative dose rate along central and lateral axis of the 106Ru/106Rh COC model plaque used for the treatment of tumors close to the optical nerve. The calculations were based on the beta-point dose function and are compared with an available data obtained by means of Monte Carlo simulations. Even with the limitations of the method, it was capable to reproduce the general trend of the dose rates around this kind of plaque and a maximum difference of -18% with MC was obtained. Despite the limitations of the method, the results may be used as a guide to future experimental and theoretical studies on this applicator, since there is a lack of available data in literature.

Radiation therapy is a valuable option for treatment of skin cancer. In order to deliver the radiation dose to the superficial skin tumor, an X-ray source, electron beam radiation therapy or a radioisotope is applied. The effectiveness of these procedures is well established in the literature. Findings of some recent studies have indicated that beta particles can be of particular interest in suppressing skin tumor growth. Betaemitting radioisotopes are favorable because of the short penetration depth of their emitted particles. Beta radiation can induce significant damage in superficial skin tumor, and at the same time, result in enhanced protection of the underlying healthy tissues. In this study, we propose the design of a patch that can be used in beta radiation therapy of skin cancer patients. For that, we describe the components of this radioactive patch, as well as a proposal for the subsequent clinical application procedure. A scaffold was used as a substrate for embedding the desired beta-emitting radioisotope, and two layers of hydrogel to provide protection and shielding for the radioactively labelled scaffold. The proposed design could provide a universal platform for all beta-emitting radioisotopes. Depending on the depth of the tumor spread, a suitable beta emitter for that specific tumor can be selected and used. This is of particular and critical importance in cases where the tumor is located directly on top of the bone and for which the depth of penetration of radiation should be limited to only the tumor volume. The proposed design has the mechanical flexibility to adapt to curved body regions so as to allow the use in anatomically challenging areas of the body.

Beta and neutron attenuations of poly(imide siloxane) block copolymers were compared to evaluate radiation penetrations into flexible sheet (BI) and pellet form BII grains. The modification of BII polymer has improved its radiation shielding properties of poly(imide siloxane) block copolymer as the result of the pelletization. The linear attenuation coefficient of BII sample was determined as ∼0.073 (1/cm) and the half value layer was at ∼9.5 cm for negative beta particles. Besides, the total macroscopic cross section was at 0.047 (1/cm) and the half value layer of BII sample was determined at 14.74 cm for neutrons. The variations of beta and neutron attenuations indicated the structural changes in the poly(imide siloxane) block copolymer depended on the critical production parameters at the production step. The pelletization of the grains of BII improved beta and neutron shielding properties of poly(imide siloxane) block copolymers for the use in medical applications. [ABSTRACT FROM AUTHOR]

Background: Brachytherapy of thin skin tumors using beta particles can protect underlying sensitive structures such as the bone because of the rapid dose falloff of this type of radiation in tissue. The current work describes a skin brachytherapy applicator, based on beta radiation, that can provide the needed cell‐killing radiation dose matched to the shape of individual skin tumors. Materials and methods: The applicator and its template were fabricated using 3D printing technology. Any clinically approved beta‐emitting isotope in the form of a radioactive gel could theoretically be used in this applicator. Monte Carlo simulations were employed to study the capability of the applicator in conforming dose distribution based on the shape of the tumor. Dose profile in the shallow depth, transverse dose profiles at different depths, and the percent depth dose from this applicator were calculated. The radioisotope of choice for our calculations was Yttrium‐90 (Y‐90). Results: Using the proposed applicator, it is possible to create a desired dose profile matching the tumor surface shape. Conclusion: The short‐range of the beta radiation, together with the dose conforming capability of the applicator, may lead to minimal interactions with the healthy tissue around the skin lesion. [ABSTRACT FROM AUTHOR]

Background: Radiation therapy using beta particles is an interesting treatment for very superficial skin lesions. Due to their low penetration in tissue and rapid dose fall‐off, beta particles can protect underlying bony structures and surrounding healthy tissue while irradiating the skin tumor. In the current work, a simple method for the fabrication of a radioactive patch for use in skin cancer therapy based on a beta‐emitting isotope is presented. Materials and methods: The beta radiation sources were Y‐90 microspheres currently used for catheter‐based radioembolization of unresectable liver tumors. The microspheres were filtered through a syringe filter to trap them on the cellulose nitrate paper of the filter and create a radioactive patch. In the current study, to avoid the need for a hot laboratory, the experiment was done using nonradioactive microspheres. An optical microscope was used to verify the distribution of the particles on the filter paper. Results: Visual evaluation of the patches showed that using the proposed method, therapeutic skin patches with a fairly uniform distribution of microspheres can be created. Conclusion: The proposed simple method may be used in creating radiotherapeutic patches using Y‐90 microspheres for radiation therapy of thin skin lesions located close to sensitive structures. [ABSTRACT FROM AUTHOR]

Nonmelanoma skin cancer (NMSC) is a major health concern due to its high incidence rate, its negative impact on the quality of life of patients as well as the associated economic burden to the healthcare system. Surgery is currently the primary treatment offered for skin cancer patients but not applicable or available in all cases. Radiation therapy (RT), with its long successful history in the management of cancer, has shown to be an effective alternative or complementary method in cutaneous oncology. Specifically, for dermatology applications, RT is very often the preferred option due to its favorable cosmetic results, besides the excellent control rate of the tumor. During the last 120 years since the introduction of treatments based on ionizing radiation, several techniques in this area have been developed. Radionuclide brachytherapy, electronic brachytherapy, X-ray therapies with kilovolt (kV) to megavolt (MV) photons and electron beam therapy are the established methods that are currently used on skin cancer patients. The purpose of this article is to overview these techniques and discuss the pros and cons of these methods in dermatology practices. Additionally, a new approach of beta RT of superficial skin tumors is discussed, which may offer exciting features in the management of NMSC. [ABSTRACT FROM AUTHOR]